placebo + oseltamivir

This is a combination of a placebo and oseltamivir. Oseltamivir is an oral antiviral medication in the neuraminidase inhibitor class, used for both treatment and prevention of influenza A and B infections. It works by inhibiting the viral neuraminidase enzyme, thereby blocking the release of new virus particles from infected cells and limiting viral spread within the body. Placebo is an inactive substance with no therapeutic effect, commonly used as a control in clinical trials to assess drug efficacy[1][2][3][5]. The combination "placebo + oseltamivir" typically refers to arms in clinical studies where one group receives active drug (oseltamivir) while another receives placebo.